Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 401 - 450 out of 12,349

Document Document Title
WO/2012/061662A9
Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells i...  
WO/2012/061662A1
Compounds, compositions and methods are provided for treating cancer and inflammatory diseases, and for releasing cells such as stem cells (e.g., bone marrow progenitor cells) into circulating blood and enhancing retention of the cells i...  
WO/2012/055010A1
The present document describes a neutraceutical, cosmeceuticals, functional food, pharmaceutical, food ingredient, and non-food ingredient compositions comprising sugar maple extract, essential oil compositions comprising oil extracted f...  
WO/2012/052596A1
The invention relates to novel inhibitors of tumour cell division. These inhibitors are semi-synthetic derivatives of neurostatin. The invention also relates to a novel method for the synthesis of the inhibitors and neurostatin. In addit...  
WO/2012/052843A1
The present invention includes novel derivatives, analogs, and intermediates of the natural products radicicol, pochonins, pochoximes, and their syntheses. The present invention also provides a pharamceutical composition comprising the p...  
WO/2012/049437A3
The invention relates to a method for transforming iota-carrageenan into alpha-carrageenan by means of a new class of 4S-iota-carrageenan sulfatase. The invention can be especially applied to the agro-food, pharmaceutical and cosmetic in...  
WO/2012/049437A2
The invention relates to a method for transforming iota-carrageenan into alpha-carrageenan by means of a new class of 4S-iota-carrageenan sulfatase. The invention also relates to carrageenans obtained by said conversion method. The inven...  
WO/2012/048119A2
The present invention provides polyphenolic compositions derived from a plant that inhibit the formation of a biofilm. Also provided are combinations that comprise at least one phenolic phytochemical and at least one antimicrobial agent ...  
WO/2012/047763A2
Flavonoid glycosides, such as isoquercitrin, are shown to stimulate the formation of neuritis and neuronal synapses in neurons and neuronal progenitor (stem) cells.  
WO/2012/045363A1
There is provided an antidiabetic enolic glucoside of phenylpyruvic acid and derivatives thereof for use as medicaments, especially normoglycemic agents, i.e. for lowering blood glucose levels to normal levels in mammals that are obese, ...  
WO/2012/042508A1
A commercially viable method is provided herein for isolating and purifying steviol glycosides from a source containing said steviol glycosides The method includes the first step of passing an organic solution containing said steviol gly...  
WO/2012/037034A1
Compounds, compositions and methods are provided for inhibiting in vitro and in vivo processes mediated by E-selectin binding. More specifically, particular glycomimetic compounds are described, wherein the compounds are E- selectin anta...  
WO/2012/021981A1
The present invention describes phytochemicals present in maple syrup and maple tree extracts by butanol, ethyl acetate and methanol. Novel compounds are isolated from maple syrups, including one compound Quebecol generated in the maple ...  
WO/2012/017199A1
Compounds of Formula (1) isolated from Bacillus spp. that act as colouring agents and/or antioxidants for use in foodstuffs and animal feed, wherein X is independently selected from methyl and COOR wherein R is independently selected fro...  
WO/2012/016994A1
The present invention relates to novel bisphosphonate duplex drugs, methods for preparing said compound; pharmaceutical compositions containing the same; as well as the use of said compounds in human and veterinary medicine, and, in part...  
WO/2012/012339A2
The present invention relates to methods and compositions for the synthesis, production, and use of pro-drug analogs of the analgesic acetaminophen. This invention relates to a method for the production of a broad group of glycosides of ...  
WO/2012/006742A9
A simple extraction method for preparing an organic certifiable stevia extract with high sweetness and optionally with antioxidant properties is provided. The extraction method involves extraction of stevia leaves that have been dried an...  
WO/2012/007585A9
The invention relates to a method for purifying, separating and/or isolating an oligosaccharide of general formula 1 or a salt thereof (general formula 1) wherein R1 is fucosyl or H, R2 is fucosyl or H, R3 is selected from H, sialyl, N-a...  
WO/2012/006742A1
A simple extraction method for preparing an organic certifiable stevia extract with high sweetness and optionally with antioxidant properties is provided. The extraction method involves extraction of stevia leaves that have been dried an...  
WO/2012/007585A1
The invention relates to a method for purifying, separating and/or isolating an oligosaccharide of general formula 1 or a salt thereof (general formula 1) wherein R1 is fucosyl or H, R2 is fucosyl or H, R3 is selected from H, sialyl, N-a...  
WO/2012/004684A3
Guanadinylated aminoglycoside-lipid conjugates are prepared. Such conjugates may comprise an aminoglycoside such as an aminoglyucoside antibiotic like neomycin or kanamycin, at least one guanidino group attached to a primary or secondary...  
WO/2011/153815A1
N-acyl modified sialic acid (α-(2→6)-D-aminopyranose derivatives, their synthesis methods and uses are disclosed. Sialic acid (α-(2→6)-D-aminopyranose derivatives represented by formula (I) are synthesized by using D-aminogalactose...  
WO/2011/154452A1
New low molecular weight complexes between iron and maltobionic acid that can be administered parenterally, preferably intramuscularly or subcutaneously, in the treatment of anemic states, caused by iron deficiencies, and new pharmaceuti...  
WO/2011/155687A1
The present invention provides a novel glycolipid derivative compound, a composition for inhibiting vascular smooth muscle cell proliferation using the same and a composition a hyper-proliferative disease of vascular smooth muscle cells ...  
WO/2011/145068A1
The present invention relates to a compound of general formula (I) in which: - X is OH, NH2, NHOH or RNH, wherein R may be a linear or branched, saturated or unsaturated, C1-C10 alkyl radical, - Y is H, or an electron-withdrawing group, ...  
WO/2011/145519A1
Disclosed are methods for producing a glucoside directly from glucose or a sugar chain comprising glucose as a structural unit. Specifically disclosed are: a method which comprises reacting glucose or a sugar chain comprising glucose as ...  
WO/2011/143497A1
The present invention relates to antimicrobial and antibiotic aminoglycoside derivatives. The compounds of the present application have the following chemical structures. The invention also relates to compositions, methods of preparation...  
WO/2011/138365A1
A process for the preparation of 1,6-Bis-[3-(3-carboxymethylphenyl)-4-(2-α-D-mannopyranosylo xy)-phenyl] hexane (I) which comprises the steps of converting the compound (2'-Methoxy-biphenyl-3-yl)-acetic acid (A) into the (2'-Methoxy-bip...  
WO/2011/137181A1
The present invention provides synthetic Moraxella catarrhalis lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various M. catarrhalis serotype-specific oligosaccharide antigens or various core M. catarrhalis ol...  
WO/2011/137181A8
The present invention provides synthetic Moraxella catarrhalis lipooligosaccharide (LOS)-based oligosaccharides and conjugates containing various M. catarrhalis serotype-specific oligosaccharide antigens or various core M. catarrhalis ol...  
WO/2011/133227A2
The present invention synthetic oligo-β-(1→6)-glucosamine structures and a methodology which essentially allows for the synthesis of any oligo-β-(1→6)- glucosamine species having a definite number of monosaccharide units, including...  
WO/2011/133227A3
The present invention synthetic oligo-β-(1→6)-glucosamine structures and a methodology which essentially allows for the synthesis of any oligo-β-(1→6)- glucosamine species having a definite number of monosaccharide units, including...  
WO/2011/125057A4
The invention relates to novel eucomic acid (2-(4-hydroxybenzyl)malic acid) derivatives or plant extracts comprising such derivatives, and also to cosmetic or dermatological compositions containing these compounds or these extracts, and ...  
WO/2011/125057A1
The invention relates to novel eucomic acid (2-(4-hydroxybenzyl)malic acid) derivatives or plant extracts comprising such derivatives, and also to cosmetic or dermatological compositions containing these compounds or these extracts, and ...  
WO/2011/124986A3
In some aspects, the present invention provides aminoglycoside derivatives thereof that exhibit antibacterial activity. In some aspects, the aminoglycoside derivatives comprise compounds consisting of (a) an ammoglycoside group and (b) a...  
WO/2011/127179A1
Compounds, compositions and methods are provided for use to inhibit infection by human immunodeficiency virus (HIV). More specifically, the present invention relates to glycomimetic compounds that inhibit HIV infection, and uses thereof.  
WO/2011/118929A3
The present invention relates to the crystal form of Epirubicin hydrochloride stable against heat and water and the preparation method thereof. The novel crystal form has the physiochemical property stable against heat and water accordin...  
WO/2011/118929A2
The present invention relates to the crystal form of Epirubicin hydrochloride stable against heat and water and the preparation method thereof. The novel crystal form has the physiochemical property stable against heat and water accordin...  
WO/2011/113373A1
Disclosed is a method for ultrasonic extraction of stevioside. Crushed dry leaves of Stevia rebaudiana serve as raw material. Based on the characteristic that an ultrasonic cavitation can reinforce the extraction of active ingredients in...  
WO/2011/110721A1
The invention relates to a method for obtaining surfactants from cellulose and hemicellulose, which comprises one reaction in a single reactor (one pot) and which includes at least the following steps: e) a first hydrolysis step, in whic...  
WO/2011/100980A1
The present invention relates to a method for preparation of the tetrasaccharide lacto-N-neotetraose (LNnt, formula (I)) especially in large scale, as well as intermediates in the synthesis, a new crystal form (polymorph) of LNnt, and th...  
WO/2011/100979A1
The present invention relates to a method for preparation of the trisaccharide 6'-0-sialyllactose (formula (I)) or salts thereof as well as intermediates in the synthesis and for the use of 6'-0-sialyllactose salts in pharmaceutical or n...  
WO/2011/098417A1
Substituted cyanobutyrates of the formula I in which the variables are defined according to the description, processes and intermediates for preparing the compounds of the formula I and their N-oxides, their agriculturally suitable salts...  
WO/2011/096536A1
Disclosed is a compound represented by general formula (1) or a salt thereof, which is capable of preferentially inducing the production of IFN-γ in NKT cells and is therefore useful for the prevention or treatment of cancer or infectio...  
WO/2011/096484A1
A read through inducer for an immature termination codon formed by a nonsense mutation, which comprises a compound represented by structure formula (A); and a therapeutic agent for nonsense-mutation-type genetic diseases, which comprises...  
WO/2011/096374A1
Provided is a novel iodobenzyl-bleomycin compound. Also provided are metal complexes that consist of the iodobenzyl-bleomycin compound and various metal atoms, such as an iodobenzyl-Co-bleomycin compound, that can accumulate on malignant...  
WO/2011/093471A1
Provided is a method for producing neoponkoranol or an analog thereof represented by structural formula [I] [wherein X- stands for a conjugated base of a Bronsted acid HX such as a carboxylate ion represented by R1COO-, a sulfonate ion r...  
WO/2011/094702A1
Steviol glycoside agglomerate compositions are disclosed that do not include binding agents or carriers.  
WO/2011/089602A3
The present invention relates to anthracycline derivatives that are based on an Aloe-emodin (AE) backbone attached to a glycoside (an amino sugar or amino carba-sugar). These derivatives are useful as chemotherapeutic agents. Advantageou...  
WO/2011/089561A1
A method of preparing a compound of formula (I): wherein: a first group selected from R1, R2 and R3 is an amino- or N-acylamino monosaccharide moiety, the acyl group having 1 to 6 carbon atoms, or an oligosaccharide chain comprising 2 to...  

Matches 401 - 450 out of 12,349